gatifloxacin has been researched along with cephalosporin c in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Bantar, C; Di Chiara, M; Lanza, A; Lopez, H; Scarano, S; Smayevsky, J; Stepanik, D; Sucari, A; Vilches, V | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Gerber, CM; Perrig, M; Täuber, MG | 1 |
| Dresser, LD; Niederman, MS; Paladino, JA | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yoshimori, K | 1 |
| Dawis, MA; France, KA; Isenberg, HD; Jenkins, SG | 1 |
| Dresser, L; Juurlink, DN; Kopp, A; Low, DE; Mamdani, MM; Park-Wyllie, LY; Shah, BR; Stukel, TA; Stumpo, C | 1 |
| Ishikawa, F; Matsuo, S; Miyazaki, S; Yamaguchi, K | 1 |
| Alali, WQ; Chen, S; Cui, S; Meng, L; Qiao, J; Wang, J; Xiao, Y; Yang, B; Yang, H; Zhang, Q | 1 |
1 trial(s) available for gatifloxacin and cephalosporin c
| Article | Year |
|---|---|
Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Decision Trees; Double-Blind Method; Female; Fluoroquinolones; Gatifloxacin; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 2001 |
9 other study(ies) available for gatifloxacin and cephalosporin c
| Article | Year |
|---|---|
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Activity of gatifloxacin compared to those of seven agents against bacteria recovered from outpatients with respiratory tract infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Outpatients; Penicillins; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae | 2000 |
Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
Topics: Animals; Anti-Infective Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Meningitis, Bacterial; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Ciprofloxacin; Dosage Forms; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Macrolides; Ofloxacin; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Urinary Tract Infections | 2002 |
In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefepime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Gatifloxacin; Gentamicins; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Thienamycins | 2003 |
Outpatient gatifloxacin therapy and dysglycemia in older adults.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Diabetes Complications; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Macrolides; Male; Ofloxacin; Ontario; Risk | 2006 |
Effect of fluoroquinolones on body temperature of mice.
Topics: Analgesics, Non-Narcotic; Animals; Body Temperature; Cephalosporins; Fluoroquinolones; Gatifloxacin; Mice; Rectum | 2008 |
Characterization of extended-spectrum β-lactamases (ESBLs)-producing Salmonella in retail raw chicken carcasses.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chickens; China; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Foodborne Diseases; Gatifloxacin; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella | 2017 |